Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis
Completed · Not applicable
Conditions studied: Kidney Failure, Chronic
In brief
OBJECTIVES: I. Assess the clinical safety and long term effects of recombinant human growth hormone on a defined range of nutritional indices in malnourished chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
Key facts
- Study ID
- NCT00004429
- Run by
- FDA Office of Orphan Products Development
- People needed
- 25
- Starts
- 1999-12-01
- Expected to finish
- 2005-02-01
- Last updated by the study team
- 2015-03-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.